Article (Scientific journals)
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Ribi, Karin; Luo, Weixiu; Colleoni, Marco et al.
2020In British Journal of Cancer, 122 (7), p. 1119
Peer Reviewed verified by ORBi
 

Files


Full Text
Correction - Quality of life under extended-converti.pdf
Author postprint (65.45 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Disciplines :
Oncology
Author, co-author :
Ribi, Karin
Luo, Weixiu
Colleoni, Marco
Karlsson, Per
Chirgwin, Jacquie
Aebi, Stefan
Jerusalem, Guy  ;  Université de Liège - ULiège > Département des sciences cliniques > Oncologie
Neven, Patrick
Di Lauro, Vincenzo
Gomez, Henry L.
Ruhstaller, Thomas
Abdi, Ehtesham
Biganzoli, Laura
Müller, Bettina
Barbeaux, Annelore
Graas, Marie-Pascale
Rabaglio, Manuela
Francis, Prudence A.
Foukakis, Theodoros
Pagani, Olivia
Graiff, Claudio
Vorobiof, Daniel
Maibach, Rudolf
Di Leo, Angelo
Gelber, Richard D.
Goldhirsch, Aron
Coates, Alan S.
Regan, Meredith M.
Bernhard, Jürg
More authors (19 more) Less
Language :
English
Title :
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Publication date :
2020
Journal title :
British Journal of Cancer
ISSN :
0007-0920
eISSN :
1532-1827
Publisher :
Nature Publishing Group, United Kingdom
Volume :
122
Issue :
7
Pages :
1119
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 01 June 2021

Statistics


Number of views
38 (1 by ULiège)
Number of downloads
11 (1 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi